Table 1 . Immunosuppressive, anti-inflammatory, and adjunctive drugs used in this study.
| Drugs | Dose | Days | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9 | -8 | -7 | -6 | -5 | -4 | -3 | -2 | -1 | ope | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | ||
| Thymoglobulin (ATG) | 10 mg/kg (i.v. 3 h) | ੦ | |||||||||||||||||
| Anti-CD20mAb (Rituximab) | 10 mg/kg (i.v. 3 h) | ੦ | |||||||||||||||||
| Abatacept | 50 mg/kg (i.v. 0.5 h) | ੦ | |||||||||||||||||
| Tacrolimus | 0.01 to 0.06 mg/kg x2/day (i.m.) | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ |
| Mycophenolate mofetil | 10 to 50 mg/kg x2/day (p.o.) | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | |||||
| Methylprednisolone | 10 mg/kg (i.v.) 0.5 to 5 mg/kg/day (p.o.) | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ||||||||
| Tocilizumab | 10 mg/kg (s.c.) | ੦ | ੦ | ||||||||||||||||
| Etanercept | 0.5 mg/kg (s.c.) | ੦ | ੦ | ੦ | |||||||||||||||
| Aspirin | 40 mg/kg/every other day (p.o.) | ੦ | ੦ | ੦ | ੦ | ||||||||||||||
| Low molecular weight heparin | 700 U/body/day (s.c. | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | |||||||||||
| Erythropoietin | 2000 U/body/twice a week (s.c.) | ੦ | ੦ | ੦ | |||||||||||||||
| Famotidine | 0.25 mg/kg x2/day (p.o.) | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ||||||||||
| Valganciclovir | 15 mg/kg/day (p.o.) | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | |||||
| Benzylpenicillin | 95000 U/body/day (i.m.) | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | ੦ | |||||||||